A matched pilot cohort study of intravenous omadacycline in the treatment of severe pneumonia associated with carbapenem-resistant Acinetobacter baumannii
BackgroundCarbapenem-resistant Acinetobacter baumannii (CRAB)-caused severe pneumonia is associated with high mortality rates, and treatment options are limited. Tetracyclines, including tigecycline and omadacycline, have in vitro activity against CRAB. We conducted this study to explore the efficac...
Saved in:
Main Authors: | Dayu Chen, Yechao Chen, Na Hu, Qiaoling Gu, Jingjing Kan, Jinchun Liu, Haixia Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1597860/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of carbapenem resistance genes in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii from meat samples
by: Maryam Rezaeian, et al.
Published: (2025-01-01) -
Synergy of ATP and Meropenem in Stimulating the TCA Cycle to Enhance Killing of Carbapenem‐Resistant Acinetobacter baumannii
by: Xia Li, et al.
Published: (2025-07-01) -
Impact of COVID-19 on epidemiology and mortality risk factors in patients with carbapenem-resistant Acinetobacter baumannii bloodstream infections in a tertiary care hospital in Thailand
by: Darunee Chotiprasitsakul, et al.
Published: (2025-06-01) -
Genotypes and β-Lactamase Gene Carriage in Carbapenem-Resistant Acinetobacter Baumannii Isolated in Moscow
by: I. V. Chebotar, et al.
Published: (2020-05-01) -
Carbapenem Resistance in <i>Acinetobacter baumannii</i>: Mechanisms, Therapeutics, and Innovations
by: Joyce de Souza, et al.
Published: (2025-06-01)